These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32057464)

  • 1. Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression.
    Frey MK; Lee SS; Gerber D; Schwartz ZP; Martineau J; Lutz K; Reese E; Dalton E; Olsen A; Girdler J; Pothuri B; Boyd L; Curtin JP; Levine DA; Blank SV
    Gynecol Oncol; 2020 Apr; 157(1):280-286. PubMed ID: 32057464
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Piedimonte S; Power J; Foulkes WD; Weber E; Palma L; Schiavi A; Ambrosio E; Konci R; Gilbert L; Jardon K; Baret L; Zeng X
    Int J Gynecol Cancer; 2020 Nov; 30(11):1757-1761. PubMed ID: 32759180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of testing for germline
    Stearnes G; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Cohen PA
    Int J Gynecol Cancer; 2019 Jul; 29(6):1038-1042. PubMed ID: 31101686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare system.
    McCuaig JM; Care M; Ferguson SE; Kim RH; Stockley TL; Metcalfe KA
    Gynecol Oncol; 2020 Sep; 158(3):747-753. PubMed ID: 32674931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers.
    Liang MI; Wong DH; Walsh CS; Farias-Eisner R; Cohen JG
    J Genet Couns; 2018 Feb; 27(1):177-186. PubMed ID: 28785836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
    Kentwell M; Dow E; Antill Y; Wrede CD; McNally O; Higgs E; Hamilton A; Ananda S; Lindeman GJ; Scott CL
    Gynecol Oncol; 2017 Apr; 145(1):130-136. PubMed ID: 28162234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
    Rana HQ; Kipnis L; Hehir K; Cronin A; Jaung T; Stokes SM; Fekrmandi F; Vatnick D; Matulonis UA; Garber JE; Wright AA
    Gynecol Oncol; 2021 Feb; 160(2):457-463. PubMed ID: 33229043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal access to genetic counseling for women with epithelial ovarian cancer in Nova Scotia: Evaluating a new collaborative care model.
    Warias A; Ferguson M; Chamberlain E; Currie L; Snow N; Matheson K; Penney LS; Kieser K
    J Genet Couns; 2021 Oct; 30(5):1491-1499. PubMed ID: 33876505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
    Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
    Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing.
    Armel SR; Volenik A; Demsky R; Malcolmson J; Maganti M; McCuaig J
    Gynecol Oncol; 2020 Aug; 158(2):440-445. PubMed ID: 32505554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.
    Cohen PA; Nichols CB; Schofield L; Van Der Werf S; Pachter N
    Int J Gynecol Cancer; 2016 Jun; 26(5):892-7. PubMed ID: 27051053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
    Uyar D; Neary J; Monroe A; Nugent M; Simpson P; Geurts JL
    Gynecol Oncol; 2018 Jun; 149(3):565-569. PubMed ID: 29653687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streamlining genetic testing for women with ovarian cancer in a Northern California health care system.
    Powell CB; Laurent C; Ciaravino G; Garcia C; Han L; Hoodfar E; Karlea A; Kobelka C; Lee J; Littell RD; Roh J; Vay A; Kushi LH
    Gynecol Oncol; 2020 Oct; 159(1):221-228. PubMed ID: 32778409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic counseling referral for ovarian cancer patients: a call to action.
    Garcia C; Harrison K; Ring KL; Sullivan MW; Rauh LA; Modesitt SC
    Fam Cancer; 2019 Jul; 18(3):303-309. PubMed ID: 30993488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first Japanese nationwide multicenter study of
    Enomoto T; Aoki D; Hattori K; Jinushi M; Kigawa J; Takeshima N; Tsuda H; Watanabe Y; Yoshihara K; Sugiyama T
    Int J Gynecol Cancer; 2019 Jul; 29(6):1043-1049. PubMed ID: 31263023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
    Powell CB; Littell R; Hoodfar E; Sinclair F; Pressman A
    Int J Gynecol Cancer; 2013 Mar; 23(3):431-6. PubMed ID: 23354368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
    Lerman C; Hughes C; Lemon SJ; Main D; Snyder C; Durham C; Narod S; Lynch HT
    J Clin Oncol; 1998 May; 16(5):1650-4. PubMed ID: 9586874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping it simple: genetics referrals for all invasive serous ovarian cancers.
    Demsky R; McCuaig J; Maganti M; Murphy KJ; Rosen B; Armel SR
    Gynecol Oncol; 2013 Aug; 130(2):329-33. PubMed ID: 23707676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis.
    Swanson CL; Kumar A; Maharaj JM; Kemppainen JL; Thomas BC; Weinhold MR; Slaby KM; Mara KC; Wick MJ; Bakkum-Gamez JN
    Gynecol Oncol; 2018 Apr; 149(1):121-126. PubMed ID: 29402500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.